The value of ixazomib in the treatment of older, frail patients with multiple myeloma
4 months ago
[{"url":"https://i.ytimg.com/vi/S92BrJXmSTA/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLCDuv9JknZQ_I_Y8oQ8yk0Qm0EMsg","width":360,"height":202},{"url":"https://i.ytimg.com/vi/S92BrJXmSTA/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLA8P2jC52ni6jb7rsnvxBkQeT0mAQ","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/S92BrJXmSTA/mqdefault_6s.webp?du=3000&sqp=CMCOsakG&rs=AOn4CLCuRcRVII6pITTRluQNUUxcGh4yiA","width":320,"height":180}
[{"text":"Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA, briefly discusses the value of ixazomib in the treatment of older,\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"The value of ixazomib in the treatment of older, frail patients with multiple myeloma by VJHemOnc \u2013 Video Journal of Hematological Oncology 37 views 4 months ago 55 seconds","duration":"55 seconds"}